Refresh

0 Hits

Rein

Die Zweckmäßigkeit der arzneimittelrechtlichen Gefährdungshaftung

Valsartan und die Folgen
Nomos,  2021, 282 Pages

ISBN 978-3-8487-8373-1


Our continuation service: You will receive new series titles or new editions automatically and without obligation to purchase. If you wish to do so, you can mark it in the shopping cart.

The work is part of the series Nomos Universitätsschriften – Recht (Volume 990)
79,00 € incl. VAT
Also available as eBook
79,00 € incl. VAT
Available
Add to shopping cart
Add to notepad
 Further options for registered users

englischIn this doctoral thesis, the medicinal product law strict liability from § 84 AMG is evaluated with regard to its expediency. First, the institute of strict liability is comprehensively explained. The focus of the work is the problem of proving causality.

It becomes clear in the work that even the presumption of causality from § 84 para. 2 AMG does not solve the problems of proof. The author argues for a lowering of the standard of proof and cites European law arguments for this. In the author's opinion, the presumption of causality from § 84 Para. 2 AMG contradicts the European Product Liability Directive, which, in the author's opinion, must guide medicinal product liability.

Find reading samples of the current title in PDF format here:
Find the cover of the current title in PDF format here:
Find further material on the current title in PDF format here: